EP2478088A1 - Lyse-puffer zur extraktion von nukleinäuren - Google Patents
Lyse-puffer zur extraktion von nukleinäurenInfo
- Publication number
- EP2478088A1 EP2478088A1 EP10755294A EP10755294A EP2478088A1 EP 2478088 A1 EP2478088 A1 EP 2478088A1 EP 10755294 A EP10755294 A EP 10755294A EP 10755294 A EP10755294 A EP 10755294A EP 2478088 A1 EP2478088 A1 EP 2478088A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- adhesive
- nucleic acid
- sample
- kit
- detergent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 175
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 175
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 175
- 239000012139 lysis buffer Substances 0.000 title claims description 14
- 230000001070 adhesive effect Effects 0.000 claims abstract description 149
- 239000000853 adhesive Substances 0.000 claims abstract description 148
- 238000000034 method Methods 0.000 claims abstract description 112
- 239000000463 material Substances 0.000 claims abstract description 93
- 239000007787 solid Substances 0.000 claims abstract description 70
- 239000012620 biological material Substances 0.000 claims abstract description 55
- 239000000203 mixture Substances 0.000 claims abstract description 47
- 239000012472 biological sample Substances 0.000 claims abstract description 39
- 239000000758 substrate Substances 0.000 claims abstract description 35
- 239000000243 solution Substances 0.000 claims description 106
- 239000000523 sample Substances 0.000 claims description 80
- 230000009089 cytolysis Effects 0.000 claims description 79
- 210000000988 bone and bone Anatomy 0.000 claims description 58
- 239000003599 detergent Substances 0.000 claims description 44
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 36
- 102000004190 Enzymes Human genes 0.000 claims description 33
- 108090000790 Enzymes Proteins 0.000 claims description 33
- 239000003638 chemical reducing agent Substances 0.000 claims description 33
- 229940088598 enzyme Drugs 0.000 claims description 33
- 210000000515 tooth Anatomy 0.000 claims description 33
- 239000002738 chelating agent Substances 0.000 claims description 32
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 26
- VHJLVAABSRFDPM-ZXZARUISSA-N dithioerythritol Chemical compound SC[C@H](O)[C@H](O)CS VHJLVAABSRFDPM-ZXZARUISSA-N 0.000 claims description 26
- 229960001484 edetic acid Drugs 0.000 claims description 26
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 25
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 claims description 24
- 239000007933 dermal patch Substances 0.000 claims description 24
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 claims description 24
- 235000019504 cigarettes Nutrition 0.000 claims description 23
- 239000006228 supernatant Substances 0.000 claims description 23
- 239000004365 Protease Substances 0.000 claims description 22
- 229940112822 chewing gum Drugs 0.000 claims description 21
- 235000015218 chewing gum Nutrition 0.000 claims description 21
- 239000000047 product Substances 0.000 claims description 21
- 239000002390 adhesive tape Substances 0.000 claims description 20
- 238000004458 analytical method Methods 0.000 claims description 18
- 239000006166 lysate Substances 0.000 claims description 18
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 16
- 239000002313 adhesive film Substances 0.000 claims description 16
- 210000000845 cartilage Anatomy 0.000 claims description 16
- 210000003041 ligament Anatomy 0.000 claims description 16
- 210000002435 tendon Anatomy 0.000 claims description 16
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 15
- 235000019506 cigar Nutrition 0.000 claims description 15
- 210000001519 tissue Anatomy 0.000 claims description 15
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- 229960003964 deoxycholic acid Drugs 0.000 claims description 14
- 229920001223 polyethylene glycol Polymers 0.000 claims description 14
- NLEBIOOXCVAHBD-QKMCSOCLSA-N dodecyl beta-D-maltoside Chemical compound O[C@@H]1[C@@H](O)[C@H](OCCCCCCCCCCCC)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 NLEBIOOXCVAHBD-QKMCSOCLSA-N 0.000 claims description 13
- GCRLIVCNZWDCDE-SJXGUFTOSA-N n-methyl-n-[(2s,3r,4r,5r)-2,3,4,5,6-pentahydroxyhexyl]nonanamide Chemical compound CCCCCCCCC(=O)N(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO GCRLIVCNZWDCDE-SJXGUFTOSA-N 0.000 claims description 13
- 108010067770 Endopeptidase K Proteins 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- AJDONJVWDSZZQF-UHFFFAOYSA-N 1-(2,4,4-trimethylpentan-2-yl)-4-[4-(2,4,4-trimethylpentan-2-yl)phenoxy]benzene Chemical compound C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OC1=CC=C(C(C)(C)CC(C)(C)C)C=C1 AJDONJVWDSZZQF-UHFFFAOYSA-N 0.000 claims description 11
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 claims description 11
- 108010076667 Caspases Proteins 0.000 claims description 11
- 102000011727 Caspases Human genes 0.000 claims description 11
- 108090000317 Chymotrypsin Proteins 0.000 claims description 11
- 108010051815 Glutamyl endopeptidase Proteins 0.000 claims description 11
- 108090000526 Papain Proteins 0.000 claims description 11
- 102000057297 Pepsin A Human genes 0.000 claims description 11
- 108090000284 Pepsin A Proteins 0.000 claims description 11
- 102000035195 Peptidases Human genes 0.000 claims description 11
- 108091005804 Peptidases Proteins 0.000 claims description 11
- 108010059712 Pronase Proteins 0.000 claims description 11
- 108090000190 Thrombin Proteins 0.000 claims description 11
- 108090000631 Trypsin Proteins 0.000 claims description 11
- 102000004142 Trypsin Human genes 0.000 claims description 11
- 229960002376 chymotrypsin Drugs 0.000 claims description 11
- 229940055729 papain Drugs 0.000 claims description 11
- 235000019834 papain Nutrition 0.000 claims description 11
- 229940111202 pepsin Drugs 0.000 claims description 11
- 235000019419 proteases Nutrition 0.000 claims description 11
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 11
- 239000000126 substance Substances 0.000 claims description 11
- 229960004072 thrombin Drugs 0.000 claims description 11
- 239000012588 trypsin Substances 0.000 claims description 11
- 229920000642 polymer Polymers 0.000 claims description 10
- 230000002934 lysing effect Effects 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 239000001913 cellulose Chemical class 0.000 claims description 5
- 229920002678 cellulose Chemical class 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 229920002472 Starch Polymers 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 229920002299 Cellodextrin Polymers 0.000 claims description 2
- 229920002307 Dextran Polymers 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920002527 Glycogen Polymers 0.000 claims description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- FYGDTMLNYKFZSV-ZWSAEMDYSA-N cellotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-ZWSAEMDYSA-N 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 229940096919 glycogen Drugs 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 239000002122 magnetic nanoparticle Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 abstract description 41
- 238000003205 genotyping method Methods 0.000 abstract description 12
- 230000001464 adherent effect Effects 0.000 abstract description 8
- 238000001514 detection method Methods 0.000 abstract description 7
- 238000011002 quantification Methods 0.000 abstract description 6
- 239000011343 solid material Substances 0.000 abstract description 4
- 108020004414 DNA Proteins 0.000 description 80
- 239000003153 chemical reaction reagent Substances 0.000 description 28
- 108091092878 Microsatellite Proteins 0.000 description 23
- 210000004369 blood Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 23
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 18
- 238000002955 isolation Methods 0.000 description 18
- 239000003112 inhibitor Substances 0.000 description 15
- 210000003296 saliva Anatomy 0.000 description 15
- 235000002639 sodium chloride Nutrition 0.000 description 14
- 238000011534 incubation Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 229920000591 gum Polymers 0.000 description 11
- 239000013060 biological fluid Substances 0.000 description 10
- 238000013382 DNA quantification Methods 0.000 description 9
- 239000004744 fabric Substances 0.000 description 9
- 239000006249 magnetic particle Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 238000007400 DNA extraction Methods 0.000 description 8
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 8
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- -1 genomic DNA and RNA Chemical class 0.000 description 8
- 238000012545 processing Methods 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 238000009472 formulation Methods 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 229920002477 rna polymer Polymers 0.000 description 6
- 108700004121 sarkosyl Proteins 0.000 description 6
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 5
- 239000000975 dye Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 210000000582 semen Anatomy 0.000 description 5
- 210000004927 skin cell Anatomy 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 4
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000000356 contaminant Substances 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 230000000670 limiting effect Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910001629 magnesium chloride Inorganic materials 0.000 description 4
- 229940041616 menthol Drugs 0.000 description 4
- 108091033319 polynucleotide Proteins 0.000 description 4
- 102000040430 polynucleotide Human genes 0.000 description 4
- 239000002157 polynucleotide Substances 0.000 description 4
- 239000001103 potassium chloride Substances 0.000 description 4
- 235000011164 potassium chloride Nutrition 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000003753 real-time PCR Methods 0.000 description 4
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 102000016911 Deoxyribonucleases Human genes 0.000 description 3
- 108010053770 Deoxyribonucleases Proteins 0.000 description 3
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 3
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000000386 athletic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002068 genetic effect Effects 0.000 description 3
- 235000011147 magnesium chloride Nutrition 0.000 description 3
- 239000011565 manganese chloride Substances 0.000 description 3
- 235000002867 manganese chloride Nutrition 0.000 description 3
- 229940099607 manganese chloride Drugs 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000003097 mucus Anatomy 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000002689 soil Substances 0.000 description 3
- 239000004575 stone Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 229920001412 Chicle Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000001794 Manilkara zapota Species 0.000 description 2
- 235000011339 Manilkara zapota Nutrition 0.000 description 2
- 108091093105 Nuclear DNA Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108091028664 Ribonucleotide Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000007605 air drying Methods 0.000 description 2
- 210000004381 amniotic fluid Anatomy 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000005547 deoxyribonucleotide Substances 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 210000003811 finger Anatomy 0.000 description 2
- 238000004374 forensic analysis Methods 0.000 description 2
- 210000004209 hair Anatomy 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000002515 oligonucleotide synthesis Methods 0.000 description 2
- JTJMJGYZQZDUJJ-UHFFFAOYSA-N phencyclidine Chemical compound C1CCCCN1C1(C=2C=CC=CC=2)CCCCC1 JTJMJGYZQZDUJJ-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000002336 ribonucleotide Substances 0.000 description 2
- 125000002652 ribonucleotide group Chemical group 0.000 description 2
- 229940071089 sarcosinate Drugs 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 1
- WKKCYLSCLQVWFD-UHFFFAOYSA-N 1,2-dihydropyrimidin-4-amine Chemical compound N=C1NCNC=C1 WKKCYLSCLQVWFD-UHFFFAOYSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- MXHRCPNRJAMMIM-SHYZEUOFSA-N 2'-deoxyuridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-SHYZEUOFSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 235000006491 Acacia senegal Nutrition 0.000 description 1
- 108700028369 Alleles Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241001247437 Cerbera odollam Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108020005196 Mitochondrial DNA Proteins 0.000 description 1
- 238000002944 PCR assay Methods 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 239000003364 biologic glue Substances 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000003467 cheek Anatomy 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 210000003109 clavicle Anatomy 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 229940009976 deoxycholate Drugs 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- MXHRCPNRJAMMIM-UHFFFAOYSA-N desoxyuridine Natural products C1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 MXHRCPNRJAMMIM-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000005021 gait Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-BUHFOSPRSA-N indigo dye Chemical compound N\1C2=CC=CC=C2C(=O)C/1=C1/C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-BUHFOSPRSA-N 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 229960002715 nicotine Drugs 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 229920002113 octoxynol Polymers 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000001047 purple dye Substances 0.000 description 1
- 238000010188 recombinant method Methods 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 210000003371 toe Anatomy 0.000 description 1
- 125000005208 trialkylammonium group Chemical group 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1006—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers
- C12N15/1013—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by means of a solid support carrier, e.g. particles, polymers by using magnetic beads
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Definitions
- the present teachings relate to the extraction of nucleic acid from solid materials such as bone, tooth and calcified tissues, or biological samples embedded or adherent to adhesive materials or denim materials.
- nucleic acid from solid biological materials such as calcified bone and tooth, or biological samples containing nucleic acids embedded and/or adherent to adhesive and gum-containing materials as well as biological materials on dried or embedded in denim materials presents sample processing challenges and potential delays in sample processing in the forensic laboratory. Forensic samples, missing person, ancient and degraded samples also have the added complication of having PCR inhibitors potentially extracted with the eluted nucleic acid.
- the present teachings provide useful compositions and methods for obtaining nucleic acids, such as genomic DNA and RNA, from a solid biological sample, an adhesive material having a biological material adherent or embedded within the adhesive substrate or a denim materials or soil,.
- the extracted nucleic acid can be used in downstream applications such as genotyping, detection, quantification, and identification of the source of the biological material where molecular biological processes such as PCR are utilized.
- the lysis solutions provided can be used to prepare high quantities of nucleic acid, such as DNA and preserve the DNA integrity extracted from calcified tissues, or biological tissues on gum and/or adhesive substrates and materials, and denim substrates and materials.
- the solutions provide highly efficient methods for DNA extraction as well methods for the removal of PCR inhibitors and methods to preclude extraction of PCR inhibitors.
- the procedure for extraction and purification of nucleic acids is fully automatable, using standard liquid handling systems.
- a composition for lysing a solid having adherent or embedded within biological material having a composition having one or more of a detergent, a chelating agent, a reducing agent, and an enzyme.
- the detergent can be an anionic detergent, an ionic detergent or a combination thereof.
- the detergent can be one or more of N-lauroyl sarcosine (NLS, also known as sarcosyl or sodium !auroyl sarcosinate), sodium deoxycholate, CTAB, dodecyl ⁇ -D-maltoside, nonanoyl-N-methylglucamide, polyethylene glycol p-(1 , 1 ,3,3- tetramethylbutyl)-phenyl ether, sodium dodecyl sulfate (SDS), and combinations thereof.
- the chelating agent can be one or more of ethylene glycol tetraacetic acid (EGTA) and ethylene diamine tetraacetic acid (EDTA), citric acid and combinations thereof.
- the reducing agent can be one or more of tris(2-carboxyethyl)phosphine (TCEP)
- the enzyme can be one or more of caspase, chymotrypsin, pepsin, proteinase K, thrombin, Staphylococcus V8 protease, pronase, papain, Bacillus sp. E1 A protease, and trypsin.
- the salt can be one or more of sodium chloride, potassium chloride, magnesium chloride, manganese chloride as well as fluorinated and iodinated forms thereof.
- the lysis solution can have a pH ranging from 5.0 - 12.0, or 5.1 , 6.0, 7.0, 8.0, 9.0, 10.0, and 1 1 .0 as well as intervals within each whole number.
- the solid sample lysed by the lysing solution has nucleic acid.
- the solid can be a biological material, an adhesive substrate, or a natural or synthetic substrate.
- the biological material can be bone, cartilage, ligament, tendon, and tooth.
- the adhesive material can be chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope, envelope flap, stamp, e.g., a postage stamp, and adhesive tape.
- a biological sample can be embedded or adhered to the adhesive material.
- the adhesive skin patch is selected from the group consisting of electronic electrode, transferable tattoo, transdermal chemical substance patch and would care dressing.
- the adhesive tape can be an adhesive bandage, athletic tape, wrapping tape, duct tape, electrical tape, hair tape, a fingerprint tape lift and so on.
- the method includes incubating a solid sample in the lysis solution and extracting a supernatant in which the nucleic acid has been extracted from the solid sample.
- the solid sample can be a biological material such as bone, cartilage, ligament, tendon, and tooth, an adhesive material such as chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope, envelope flap, stamp, a fingerprint tape lift, and adhesive tape, a denim material.
- the method can also include shaking and/or vortexing the solid sample in the lysis solution while the mixture is incubated, centrifuging the solid sample in the lysis solution after incubation, lysing the biological sample, biological material and/or solid sample in the lysis solution to form a lysate having nucleic acid and extracting the lysate to obtain a product with nucleic acid.
- the method can also include shaking the solid with the lysis solution and extracting the lysate to obtain a product with nucleic acid separate from the solid.
- the nucleic acid recovered from a fingerprint tape lift using the methods described herein can be used for identification of the organism from which the biological material was obtained.
- the nucleic acid can be used in genotyping assays for STRs, HLA markers and RFLP typing, Y-STR and Y-SNP typing, mtDNA sequencing, and insertion/deletion polymorphisms typing.
- the fingerprint can be used for comparison to a fingerprint collection and/or a database of fingerprints.
- kits for extracting nucleic acid from a solid such as a biological material, an adhesive material or substrate, and denim material or substrates having epithelial, blood, semen, saliva or other biological fluids known to one of skill in the art.
- the kit has at least one of a first detergent, a chelating agent, a reducing agent, and an enzyme either as separate solutions of each or in combinations.
- the kit can also have optional solutions such as a solution having a polymer.
- the polymer comprises one or more of dextran, cellulose, cellulose derivatives, soluble starch, dextrin, cellodextrin, polyethylene glycol, heparin, glycogen, and combinations thereof.
- the kit can also have a second detergent, a wash solution, a second wash solution, DNase free water, a magnetic device, and magnetically attractable particles comprising dextran-encased magnetic nanoparticles.
- Applicants have provided embodiments for nucleic acid extraction methods from samples containing minute nucleic acid quantities. Embodiments of such methods are rapid, eliminate use of strong organic solvents, simplify processing and reduce sample handling and risks of cross-contamination with improved user safety.
- FIG. 1 is a graph depicting the Intercolor balance (ICB) between STR alleles for blood replicates extracted from denim. ICB was calculated by dividing maximum peak height by minimum peak height in each color (heterozygotes peaks are average and homozygotes divided by 2). Samples are listed in Table 6.
- ICB Intercolor balance
- X and/or Y can mean “X” or ⁇ " or "X and Y”.
- the use of “comprise, “ “comprises, “comprising, “ “include, “ “includes, “ and “including” are interchangeable and not intended to be limiting.
- the description of one or more embodiments uses the term “comprising, " those skilled in the art would understand that, in some specific instances, the embodiment or embodiments can be alternatively described using the language “consisting essentially of” and/or “consisting of”.
- the term “and/or” means one or all of the listed elements or a combination of any two or more of the listed element.
- the practice of the present invention may employ conventional techniques and descriptions of organic chemistry, polymer technology, molecular biology (including recombinant techniques), cell biology, biochemistry, and immunology, which are within the skill of the art.
- Such conventional techniques include oligonucleotide synthesis, hybridization, extension reaction, and detection of hybridization using a label.
- Specific illustrations of suitable techniques can be had by reference to the example herein below.
- other equivalent conventional procedures can, of course, also be used.
- Such conventional techniques and descriptions can be found in standard laboratory manuals such as Genome Analysis: A Laboratory Manual Series (Vols.
- the term "adhere” refers to the bond between at least two items or surfaces or the binding of at least two items or surfaces together.
- the bond can be a fusing, gluing, or sticking together of the at least two items or surfaces.
- the term "adhesive" refers to a substance capable of binding at least two items.
- the adhesive can be a cement, glue, paste, starch, gum or chemical compound or polymer from a natural or synthetic source and can be applied to an envelope, film, label, paper, patch, stamp or tape as one of the at least two items.
- the adhesive can be a liquid or a solid or form a solid upon drying by evaporation or heating, ultra-violet light curing, or other physical means.
- the first item can have the adhesive integral to it, e.g., gum or applied to it, e.g., tape.
- the first item comprises the adhesive such that the first item can be bound in a removable, temporary, semipermanent or permanent status with respect to the bond it forms with an at least second item.
- the adhesive can be made soluble or be made sticky by the application of a liquid such as saliva.
- a liquid such as saliva.
- a stamp is licked by a tongue prior to its application to an envelope.
- Another example can be the flap of an envelope which when licked, such that the adhesive on the flap of the envelope becomes sticky and then when folded over to close the envelope opening, creates a seal due to the adhesive holding the envelope flap in constant, virtually permanent, contact with the envelope.
- adheresive material and “adhesive substrate” are used interchangeably and refer to items containing or have integral to its composition an adhesive, sticky surface or adhesive composition, e.g., chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope flap, stamp, an adhesive tape used for lifting fingerprints, biological, organic or inorganic materials and adhesive tape.
- adhesive, sticky surface or adhesive composition e.g., chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope flap, stamp, an adhesive tape used for lifting fingerprints, biological, organic or inorganic materials and adhesive tape.
- adheresive film refers to a thin flexible sheet that can adhere to an item.
- the film can be permanently adhered to the item or is removable.
- adheresive label or “adhesive sticker” refers to an item having identifying information or design on an upper surface that can adhere to another item or surface by the surface opposite the identifying information or design.
- the label can permanently adhere to the other item or is removable.
- adheresive paper refers to a paper (cellulose, wood pulp derived, vinyl, plastic or synthetic paper) with an adherent surface that forms a removable, temporary, semi-permanent or permanent bond with respect to the surface to which it is attached, e.g., envelope, postage stamp, re-adherable stationary or sticky note, or sticker.
- adheresive skin patch refers to a round, oval, rectangular or other shape that can adhere in a removable fashion to an intact or damaged (wound) dermal surface, e.g., an EKG electrode, a transferable tattoo, a nicotine patch, and a plaster.
- adheresive tape refers to a flexible strip or band that can adhere to another item or surface, e.g., athletic tape, wrapping tape, Scotch® brand tape.
- the tape can be permanently adhered to the other item or removable.
- the tape can be soluble or insoluble in an aqueous or organic solution.
- biological material refers to blood, mucus, semen, saliva, skin tissue, bone, cartilage, ligament, tendon, tooth, fingerprint, etc.
- the biological material can be a calcified, hardened, solid and a natural composition of biological origin.
- the biological material can have a solid, fluid, tissue or cells comprising nucleic acid.
- the biological material can include but is not limited to, nucleic acid comprising material recovered from an adhesive and/or sticky material including, but not limited to, chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope, envelope flap, stamp, a fingerprint tape lift and adhesive tape.
- biological sample refers to a biological material adherent to or imbedded in an adhesive material, e.g., blood, mucus, semen, saliva, skin cell, skin tissue, bone, cartilage, ligament, tendon, tooth, a fluid, tissue or cells.
- an adhesive material e.g., blood, mucus, semen, saliva, skin cell, skin tissue, bone, cartilage, ligament, tendon, tooth, a fluid, tissue or cells.
- the biological sample comprises nucleic acid.
- DNA refers to deoxyribonucleic acid in its various forms as understood in the art, such as genomic DNA, cDNA, isolated nucleic acid molecules, vector DNA, and chromosomal DNA.
- Nucleic acid refers to the nucleic acid molecule or molecules, DNA or RNA (ribonucleic acid) in any form.
- nucleic acid molecule or “extracted nucleic acid” refers to a nucleic acid molecule (DNA or RNA of any form) that has been recovered from its native environment.
- extracted nucleic acid molecules are partially or substantially purified nucleic acid molecules, nucleic acids obtained from forensic and other samples comprising biological material, such as blood, mucus, semen, saliva, skin tissue, bone, cartilage, ligament, tendon, and tooth, etc.
- biological material recovered from an adhesive and/or sticky material including but not limited to, chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope, stamp, and adhesive tape, as well as in nucleic acid samples derived from archeological, crime scene processing, forensic, human identification, natural and mass disaster scenes collected by forensic, crime, research, search and rescue, and recovery methods and techniques.
- fingerprint and “fingerprint image” are used interchangeably herein and refer to friction skin ridge impressions made when the epidermal ridges and indentations of the skin found on a ventral surface of a digit, including but not limited to, fingers and toes, a thumb, as well as a palm and a sole of a foot, contact a surface.
- genomic DNA refers to the nucleic acids comprising the chromosomal DNA sequence of a gene or segment of a gene, including the DNA sequence of noncoding as well as coding regions.
- Genomic DNA also refers to DNA isolated directly from biological samples e.g., bone, tooth, tissue, cells or chromosomes or the cloned copies of all or part of such DNA.
- Genomic DNA also refers to DNA extracted from an adhesive or sticky material e.g., chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope, stamp, and adhesive tape.
- Gum can be of natural or synthetic origin. Natural gum can be latex, gum Acacia, Guar gum, Chicle and Chicle varieties such as chicoo and chicozapote. Synthetic gum can be polyisobutylene.
- denim material and “denim substrate” are used interchangeably and refer to materials of either animal or vegetable origin.
- the denim material composed entirely of cotton or cotton blended with natural or synthetic fibers.
- the cotton denim fabric can include but is not limited to blue, dark blue, black, stone- washed, acid washed and the like.
- polynucleotide As used herein, the terms “polynucleotide”, “oligonucleotide”, and “nucleic acid” are used interchangeably herein and refer to single-stranded and double-stranded polymers of nucleotide monomers, including without limitation 2'-deoxyribonucleotides (DNA) and ribonucleotides (RNA) linked by internucleotide phosphodiester bond linkages, or internucleotide analogs, and associated counter ions, e.g., H + , NH 4 + , trialkylammonium, Mg 2+ , Na + , and the like.
- DNA 2'-deoxyribonucleotides
- RNA ribonucleotides linked by internucleotide phosphodiester bond linkages
- counter ions e.g., H + , NH 4 + , trialkylammonium, Mg 2+ , Na + , and the like
- a polynucleotide may be composed entirely of deoxyribonucleotides, entirely of ribonucleotides, or chimeric mixtures thereof and can include nucleotide analogs.
- the nucleotide monomer units may comprise any nucleotide or nucleotide analog.
- Polynucleotides typically range in size from a few monomeric units, e.g. 5-40 when they are sometimes referred to in the art as
- oligonucleotides to several thousands of monomeric nucleotide units. Unless denoted otherwise, whenever a polynucleotide sequence is represented, it will be understood that the nucleotides are in 5' to 3' order from left to right and that "A" denotes
- solid refers to a material that is not a liquid such as an adhesive containing material as well as hardened, dense materials having a matrix such as calcified biological materials e.g., bone, tooth, as well as cartilage, tendon and ligament and common dust which is composed of sloughed skin cells.
- the solid can contain or is suspected of containing a nucleic acid.
- solid sample refers to a hard, dense material, likely a biological material such as bone, cartilage, ligament, tendon and tooth or an adhesive material that is nonporous and/or water insoluble and contains or is suspected of containing a nucleic acid.
- compositions, methods and kits are described in which nucleic acid molecules can be separated and/or extracted from samples and, in some embodiments, in which the product made from the compositions, methods and kits are nucleic acids.
- the compositions, methods and kits of the present teachings result in the formation of a product which comprises the extracted nucleic acid.
- compositions wherein a sample can be treated with a lysis solution comprising at least one each of a detergent, a chelating agent, a reducing agent, and an enzyme, and combinations thereof in order to extract nucleic acid molecules from the sample.
- a lysis solution comprising at least one each of a detergent, a chelating agent, a reducing agent, and an enzyme, and combinations thereof in order to extract nucleic acid molecules from the sample.
- the sample can comprise one or more of free nucleic acids; extracted from solid matrices including, but not limited to, biological materials such as bone, cartilage, ligament, tendon, and tooth, and so on.
- the sample can comprise nucleic acid extracted from adhesive materials, including, but not limited to, materials such as chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope flap, stamp, a fingerprint tape lift and adhesive tape.
- the sample can comprise nucleic acid extracted from denim materials including, but not limited to, denim fabric including blue, dark blue, black, stone-washed, acid washed and the like.
- a nucleic acid can be extracted from a sample, comprising the steps of incubating the sample with a solution comprising one or more of a detergent, a chelating agent, a reducing agent, a salt and an enzyme; and extracting the supernatant.
- the incubation can be at room temperature, 35 °C, 40 ⁇ C, 41 ⁇ C, 42°C, 43 ⁇ C, 44 °C, 45 °C, 50°C, 51 °C, 52 °C, 53 ⁇ C, 54 ⁇ C, 55 ⁇ C, 56°C, 57°C, 58 ⁇ C, 59 °C, 60 ⁇ C, 65 °C and 70 ⁇ C, as well as intervals therein.
- Such methods may further comprise the steps of centrifuging the incubation solution to remove solids from the supernatant and treating the supernatant to isolate the nucleic acids.
- the nucleic acids thus obtained can then be utilized in any of various downstream applications and analyses such as, for example, quantification, detection, and genotyping of specific nucleic acids or even of a biological species. These analyses can be performed, for example, by PCR amplification. As one example, in forensic DNA analysis the human nuclear DNA (nDNA) and/or genomic DNA can be obtained from complex biomaterials and then genotyped using PCR.
- nDNA human nuclear DNA
- genomic DNA can be obtained from complex biomaterials and then genotyped using PCR.
- a DNA preparation can be used for quantification of human DNA, or more specifically human male DNA, using real-time PCR systems such as Quantifier® or Quantifiler Duo® kits (Applied Biosystems/Life Technologies Corp., Foster City, CA), and/or genotyped for autosomal or Y-chromosomal short tandem repeat loci using systems such as, for example, AmpF/STR ® kits.
- PCR systems such as Quantifier® or Quantifiler Duo® kits (Applied Biosystems/Life Technologies Corp., Foster City, CA)
- genotyped for autosomal or Y-chromosomal short tandem repeat loci using systems such as, for example, AmpF/STR ® kits.
- a particular genotyping system can be selected that will yield the best results for the particular analysis required. Therefore, in order to best utilize nucleic acids in downstream applications, it is particularly desirable that the extraction and isolation methods result not only in a product of high yield, but also one that is relatively free of inhibitors of downstream applications such as PCR.
- forensic evidence samples are variable in sample types, substrate or matrix wherein the biological materials are embedded, including but not limited to, solid biological samples or the surface upon which the forensic sample was collected, which can result in sample exposure to environmental insults, contamination by PCR inhibitors and limit the quantity of starting sample material.
- Extraction of nucleic acid including, but not limited to, DNA from forensic evidence samples, often exposed to temperature variation, excessive moisture or dehydrating conditions, and sample contaminants as would be known to one of ordinary skill in the art during acquisition and processing, can lead to difficulties in isolation of nucleic acid and the potential of contamination with compounds, e.g., dye or other chemical treatments of denim fabric that act to inhibit PCR, and which therefore interfere with attempts at genotyping or other analyses.
- forensic samples can employ adhesive materials in sample collection or be a component of the sample itself.
- the presence of the adhesive often decreases the overall recovery of nucleic acid as the adhesive can interfere with the isolation process as when particulates are used to isolate the nucleic acid.
- nucleic acid extracted from cigarette butts, chewing gum, and dried blood, saliva and biological material (including skin cells and cells from a fingerprint) in a tape lift resulted in higher nucleic acid recoveries and was free of PCR contaminants when profiled by short tandem repeat (STR) analysis.
- STR short tandem repeat
- Another example of difficult forensic samples are solid biological materials including, but not limited to, calcified tissues such as bone and tooth.
- the dense matrix requires lengthy, labor intensive processes, often lasting more than 24 hours, before minute amounts of nucleic acid are extracted.
- the disclosed teachings achieved maximum recovery of DNA by disruption of the calcified matrix so that the majority of the biological material is exposed to the lysis reagent solution.
- the yield of DNA from bone and tooth samples is summarized in Table 1 . In examples to follow the time required to extract nucleic acid from bone and tooth at optimum yield was achieved after only two hours.
- Various embodiments of the present teachings relate to efficient extraction of nucleic acids such as, for example, genomic DNA in such a quantity that subsequent isolation and elution of the nucleic acid using the PrepFilerTM Forensics DNA Extraction Kit (P/N 4392852 or 4392353, Applied Biosystems, Foster City, CA) provides nucleic acid suitable for DNA quantification and analyses.
- Embodiments of these teachings thus enable effective extraction of nucleic acids, such as genomic DNA, from various solid types of biological materials, adhesive comprising materials as well as biological fluid samples from denim.
- nucleic acids such as genomic DNA can be isolated from either small or large quantities of the biological materials that are commonly processed in laboratories such as, for example, those involved in genotyping analyses.
- Embodiments of the lysis solution provided herein can comprise a mixture of a chelating agent (preferably ranging from 250-500 mM), such as ethylene glycol tetraacetic acid (EGTA) and/or ethylene diamine tetraacetic acid (EDTA) and/or citric acid; detergents (preferably ranging from 0.1 % to 3%), such as at least one of N-lauroyl sarcosine, sodium deoxycholate, CTAB, N-dodecyl ⁇ -D-maltoside, nonanoyl-N- methylglucamide, Triton ® X-100, NP-40, and/or sodium dodecyl sulfate; a salt (ranging from 50 mM to 500 mM), such as sodium chloride, potassium chloride, magnesium chloride, manganese chloride as well as fluorinated and iodinated forms thereof; and reducing agent (preferably ranging from 10 to 100 mM), such
- E1 A protease, and trypsin. Tables provided below indicate the extraction efficiency as a comparison of various incubation times in the lysis solution, quantity and type of starting solid, adhesive or denim material.
- the lysis solution extracts the nucleic acid from the solid matrices or adhesive material such that the nucleic acid supernatant can be isolated and cleansed of impurities using the PrepFilerTM Kit.
- Various embodiments of the present teachings relate to a lysis solution and methods of using the solution, amenable to assembly in a kit, for the extraction of nucleic acids including, but not limited to, genomic DNA, from adhesive materials containing biological samples and solid samples, such as biological samples, thought to contain or known to comprise nucleic acid.
- the adhesive material can be for example, a tape lift collected by forensic methods, e.g., a dried blood, saliva and fingerprint, as well as an envelope flap, stamp, including but not limited to a postage stamp, trading stamp, hunting license stamp, conservation stamp, chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, adhesive paper, adhesive skin patch, envelope, stamp, and adhesive tape and such.
- the adhesive material is thought to contain nucleic acid attached or embedded in the adhesive material and the present teachings relate to the extraction of the nucleic acid, if present, from the adhesive material sample.
- Adhesive material has been shown to interfere with subsequent nucleic acid isolation, purification and overall yield when using the PrepFilerTM kit .
- the adhesive interferes with the handling of the magnetic particles, in the polymer-nucleic acid-magnetic particle complex formed in the PrepFiler protocol.
- the formation of the complex is such that the polymer entraps the nucleic acid, polymer attaches to magnetic particles, and so indirectly connects the nucleic acid with the magnetic particles until the complex is washed to remove contaminants and inhibitors such that the nucleic acid is amendable to use in downstream applications, such as PCR.
- Obtaining nucleic acid from the adhesive containing sample was difficult, tedious and of low yield prior to the development of the lysis solution taught herein.
- the dyes, pigments and fibers found in denim fabric as is used in the manufacture has been found to inhibit STR analysis of nucleic acids isolated therefrom in genotyping assays such as the Identifiler® kit (Applied Biosystems).
- the fibers appear to complex with the pigments or dyes and interferes with the handling of the magnetic particles, in the polymer-nucleic acid-magnetic particle complex formed in the PrepFiler protocol. This has made obtaining nucleic acid from the denim sample compromised by PCR inhibitors, DNA recovery is difficult, tedious and of low yield prior to the development of the Tris-CI lysis solution taught herein.
- a nucleic acid extraction such as for genomic DNA
- methods and kits for extraction of the nucleic acids from solid biological samples including, but not limited to, bone, cartilage, ligament, tendon, and tooth, and adhesive.
- Embodiments of these methods can comprise: cleaning the solid sample with a mild detergent solution, air- drying overnight, removing the exterior layer with a sanding stone, and pulverizing the sample.
- the prepared sample is then incubated with lysis solution such that the nucleic acid containing cells are released from the solid matrix.
- the solid biological material contains nucleic acid and the present teachings relate to the extraction of the nucleic acid from the solid material.
- Calcified and hardened biological materials have been shown to provide low yields of nucleic acid when using the PrepFilerTM kit (Applied Biosystems, Foster City, CA), because the solid matrices provide unique challenges for the extraction and isolation of nucleic acid.
- the yield of nucleic acid from the solid biological material has been improved by use of the lysis solution taught herein prior to the PrepFiler protocol.
- Standard nucleic acid isolation techniques including cell lysis, and washing and elution of nucleic acids, are well known in the art and unless otherwise noted, can be carried out according to various techniques as described, for example, in DNA Typing Protocols: Molecular Biology and Forensic Analysis, 1 st edition, B. Budowle et ai, eds., Eaton Publishing Co. (2000); JM Butler, Forensic DNA Typing: Biology, Technology, and Genetics of STR Markers, 2 nd edition, Elsevier Academic Press (2005); or P.
- nucleic acids are more easily isolated and purified when using the PrepFiler protocol for nucleic acid containing adhesive materials and solid biological samples by using the lysis reagent solution taught herein having one or more of a detergent, a chelating agent, a reducing agent, a salt, and an enzyme.
- the lysis solution improves the efficiency and yield of nucleic acids, such as genomic DNA, from adhesive materials, solid biological samples.
- the detergent can be ionic or anionic.
- N-lauroyl sarcosine N-lauroyl sarcosine
- lauroyi sarcosinate also known as sarcosyl
- an ionic surfactant derived from sarcosine hexadecyltrimethylammonium bromide or cetyltrimethylammonium bromide (CTAB)
- deoxycholate sodium citrate; sodium deoxycholate; dodecyl ⁇ -D- maltoside; nonanoyl-N-methylglucamide; sodium dodecyl sulfate
- polyethylene glycol p- (1 ,1 ,3,3-tetramethylbutyl)-phenyl ether commercially known as Triton ® X-100
- the detergent comprises NLS in the range of 0.5 to 3% w/v.
- appropriate chelating agents are, but not limited to, ethylene diamine tetraacetic acid (EDTA); ethylene glycol-bis(2-aminoethyl)-N,N,N',N'- tetraacetic acid (EGTA) and citric acid in the range of about 250 to 750 mM.
- appropriate reducing agents include but are not limited to, tris(2- carboxyethyl)phosphine (TCEP) dithioerythritol (DTE), and dithiothreitol (DTT) in the range of about 10 to 100 mM, prepared fresh prior to use.
- enzymes are, but not limited to, caspase, chymotrypsin, pepsin, proteinase K, thrombin, Staphylococcus V8 protease, pronase, papain, Bacillus sp. E1 A protease, and trypsin in the range of 0.5 to 10 mg/ml final concentration in the lysis solution.
- the lysis solution is prepared just before use by combining the chelating agent, at a pH of about 7.5 to 8.5 with detergent and salt, followed by adding the reducing agent solution and the enzyme.
- the chelating agent is prepared in a solution having the detergent with or without the salt, the reducing agent is freshly prepared, and the enzyme is in solution.
- the salt is either in solution or present in the detergent solution. The solutions can then be combined just prior to use to form the lysis solution.
- a lysis solution can be prepared and then freeze-dried.
- the freeze-dried lysis reagent can then be solubilized just prior to use.
- Such methods of freeze-drying are conventional and known to one of ordinary skill in the art.
- the result of a freshly prepared lysis solution is that the components have not degraded or oxidized such as may occur with prolonged storage or exposure to light and therefore decrease nucleic acid extraction and overall yield of nucleic acid.
- the adhesive material or solid biological material is incubated at from about 50 Q C to 70 Q C for two hours to release cellular material from adhesive materials or solid biological matrices with 56 Q C being a common temperature used.
- the natural or synthetic material is incubated at from about 40 Q C to 70 Q C for 40 min to 1 hour.
- the extraction can be assisted by shaking.
- the lysis solution further comprises compounds to protect the released nucleic acids and maintain their compatibility for use in downstream assays such as, for example, PCR assays, and in particular DNA genotyping systems, for example STR assays.
- the sample can be centrifuged to pellet residual solid tissue,or adhesive material.
- the resulting supernatant product comprises nucleic acids.
- the supernatant is suitable for nucleic acid isolation and purification using methods known to one of ordinary skill in the art or commercial nucleic acid isolation and purification products such as the PrepFilerTM Kit.
- the kit can be use to remove cellular debris, residual contaminants and/or inhibitors of PCR.
- nucleic acid molecules can be isolated from solid matrices including biological samples including but not limited to: bone; cartilage; ligament; tendon; and tooth.
- the biological sample is calcified, mummified, baked or otherwise in a natural or preserved state.
- the solid biological sample is fragmented, crushed, pulverized or otherwise ground into a fine particulate, such as a powder.
- the yield of nucleic acid, such as DNA is variable depending upon the age of the solid material, the amount of starting material and the degradation or preservation of the sample. The yield of the nucleic acid as DNA from bone and tooth samples is summarized in Table 1
- the yield of DNA from 100 mg of long bone samples ranged from 0.25 to 2.15 ng, which is typical of such a sample type since each bone sample is unique in the content and state of biological material.
- the C T values for internal PCR control (IPC) determined by the Quantifiler® Human DNA Quantification Kit (Applied Biosystems) for the bone samples tested did not increase significantly compared to that for the non- template control (NTC, Table 1 ). If the DNA extract contained PCR inhibitors, typically an upward shift in C T value for the sample compared to the IPC C T value for the NTC would be expected (Applied Biosystems, Quantifiler ® Human DNA Quantification Kit and Quantifiler ® Y Human Male DNA Quantification Kit. User's Manual. PN 4344790 Rev. B, (2003)).
- the PCR inhibitors present in bone and tooth samples have been efficiently removed during the extraction of DNA using the lysis reagent solution followed by isolation and purification with the PrepFilerTM kit reagents.
- NTC Bone samples were of unknown age. Tooth sample was 1 year old.
- the quantity of bone sample tested for optimum extraction and yield of nucleic acid varied from 50 mg to 200 mg and the volume of the lysis solution supernatant collected was adjusted, whenever necessary, to 200 ⁇ _ using PrepFilerTM lysis buffer prior to isolation of DNA.
- the total yield of DNA was almost doubled when the quantity of bone powder was increased from 25 to 50 mg powder (Table 2). Further increase in the quantity of bone powder increased the yield of DNA but the incremental increase in the yield of DNA was not proportional to the quantity of bone powder.
- the evaluation was conducted in triplicate.
- the volume of lysis solution supernatant recovered after incubation of 200 mg of bone powder was 130 ⁇ _ compared to 200 ⁇ _ from 50 mg of bone powder. Therefore, processing of bone powder greater than 200 mg did not appreciably increase DNA yield.
- DNA extracts from seven long bone samples were processed for STR analysis using AmpF/str® Identifiler ® and MiniFilerTM kits (Applied Biosystems), following the manufactures protocol.
- the results are summarized in Table 4.
- the Identifiler Kits amplifies a total of 16 STR loci and the MiniFiler kit amplifies 9 STR loci.
- conclusive loci are compared to the total amplifiable loci for each of the kits.
- Bone-4 sample provided a complete STR profile using both kits.
- Bone-6 did not provide results when amplified using the Identifier ® kit but provided amplification of only 4 loci using the MiniFilerTM kit.
- the MiniFilerTM kit is designed to obtain profiles from degraded DNA samples (J.J. Mulero, et al., J. Forensic Sci. (2008) 53:838-852). The results indicate that the bone samples were aged and degraded to different extent.
- the present teachings include using a plurality of samples ranging from when only trace amounts of biological material is potentially present.
- the sample amount can range from 50 to 200 mg of calcified tissue or solid biological sample in each tube and then the supernatants are combined and
- nucleic acid molecules can be isolated from adhesive materials, including but not limited to: chewing gum; cigar butt; cigarette butt; adhesive film; adhesive label; adhesive paper; adhesive skin patch; envelope flap, stamp, and dried blood, dried saliva, environmental sampling, including but not limited to dust, soil, dirt and a fingerprint via an adhesive tape lift, and adhesive tape.
- the adhesive skin patch includes, but is not limited to: EEG or EKG electronic electrode; transferable tattoo; transdermal chemical substance patch and would care dressing.
- the adhesive tape includes, but is not limited to: tape; athletic tape; forensic tape; and so on.
- the adhesive paper includes, but is not limited to envelope, removable paper, stamp and so on.
- a Tris-CI Lysis Solution can be used to isolate nucleic acid molecules from denim materials containing on the surface or embedded within a biological fluid sample including but not limited to, for example, hair, feces, blood, tissue, urine, saliva, cheek cells, vaginal cells, skin, for example skin cells contained in fingerprints, buccal sample, amniotic fluid containing placental cells, and amniotic fluid containing fetal cells, and semen.
- the biological fluid can be moist, wet, dried or adherent to the denim material.
- the biological fluid sample can be found within an environmental sample such as soil.
- the method can also include heating or incubating a Tris-CI lysis solution with the denim substrate containing the biological fluid material.
- the Tris-CI lysis solution is centrifuged to separate the nucleic acid containing lysate from the substrate.
- compositions wherein a sample can be treated with a Tris-CI lysis solution comprising Tris-chloride (Tris-CI), at least one each of a detergent, a chelating agent, a reducing agent, and an enzyme, and combinations thereof in order to extract nucleic acid molecules from the denim substrate sample.
- Tris-CI Tris-chloride
- the detergent can be one or more of N-lauroyl sarcosine, sodium deoxycholate, CTAB, dodecyl ⁇ -D-maltoside, nonanoyl-N-methylglucamide, polyethylene glycol p-(l,l,3,3-tetramethylbutyl)-phenyl ether, sodium dodecyl sulfate (SDS), and combinations thereof.
- the chelating agent can be one or more of ethylene glycol tetraacetic acid (EGTA) and ethylene diamine tetraacetic acid (EDTA), citric acid and combinations thereof.
- the reducing agent can be one or more of tris(2- carboxyethyl)phosphine (TCEP) dithioerythritol (DTE), and dithiothreitol (DTT).
- the enzyme can be one or more of caspase, chymotrypsin, pepsin, proteinase K, thrombin, Staphylococcus V8 protease, pronase, papain, Bacillus sp. EIA protease, and trypsin.
- the salt can be one or more of sodium chloride, potassium chloride, magnesium chloride, manganise chloride as well as fluorinated and iodinated forms thereof.
- the lysis solution can have a pH ranging from 5.0 - 12.0, or 5.1, 6.0, 7.0, 8.0, 9.0, 10.0, and 11.0 as well as intervals within each whole number.
- the sample can comprise nucleic acid extracted from denim materials including, but not limited to, denim fabric including blue, dark blue, black, stone-washed, acid washed and the like.
- methods are described wherein a nucleic acid can be extracted from a sample, comprising the steps of incubating the sample with a solution comprising Tris- Cl, one or more of a detergent, a chelating agent, a reducing agent, a salt and an enzyme; and extracting the supernatant.
- the incubation can be at room temperature, 35 ⁇ C, 40 ⁇ C, 41 ⁇ €, 42 °C, 43°C, 44 °C, 45 °C, 50°C, 51 °C, 52 ⁇ C, 53 ⁇ C, 54 ⁇ C, 55°C, 56°C, 57 ⁇ C, 58 ⁇ C, 59 ⁇ €, 60 °C, 65 °C and 70 ⁇ C, as well as intervals therein.
- Such methods may further comprise the steps of centrifuging the incubation solution to remove solids from the supernatant and treating the supernatant to isolate the nucleic acids.
- inhibitors of PCR can be extracted or released into the lysate or eluate during the process of nucleic acid extraction resulting in poor quality DNA.
- the quality of the nucleic acid extracted or recovered from a biological fluid sample can adversely impact analysis of the nucleic acid in processes such as, for example, quantification, detection, and genotyping of specific nucleic acids or a biological species.
- the Tris-CI can be at a concentration of from 10 mM to 600 mM and at a pH of from 5 to 12.
- the detergent can be present at from 0.1 % to 5.0% and the chelating agent can be present at from about 1 .0 mM to 600 mM at a pH of from 7.0 to 8.5 (adjusting pH with 0.5 - 1 M NaOH).
- appropriate salts include, but are not limited to, sodium chloride, potassium chloride, magnesium chloride, manganese chloride as well as fluorinated and iodinated forms thereof in the range of about 1 mM to 1 M.
- the enzyme concentration is in the range of 1 mg/uL to 50 mg/mL and the reducing agent
- concentration is in the range of 10 mM to 1 M.
- the DNA quality using the disclosed Tris-CI-buffered lysis reagent solution were sufficient to obtained full STR profiles for each sample tested. These results show that the disclosed Tris-CI-buffered lysis reagent solution can provide high quality nucleic acid even in the presence of indigo, black dye, and chemical treatments, known PCR inhibitors.
- nucleic acid molecules can be isolated from denim using Tris-CI-buffered lysis reagent solution.
- the lysis reagent solution was shown to disrupt calcified tissue matrices, achieve effective DNA extraction from pulverized bone and tooth samples as well as from adhesive materials such as tape, chewing gum, envelope, stamp and cigarette butts
- the results for denim materials for the STR profiles demonstrated that the DNA obtained was free of any PCR as shown in Figures 1 -4.
- the Tris-CI-buffered lysis reagent solution was shown to achieve effective DNA extraction from denim samples.
- Both the lysis reagent solution and the Tris-CI -buffered lysis reagent solution resulted in improved recovery of nucleic acid, improved DNA isolation, purification and the DNA was absent interfering materials and impurities that would compromise or impede further analyses such as PCR, realtime PCR and STR profiling.
- the nucleic acid recovered from a fingerprint using the methods described herein can be used for identification of the organism from which the biological material or biological sample containing the nucleic acid was obtained as discussed supra.
- the fingerprint image can be used for comparison to a forensic database including but not limited to a fingerprint collection and/or a database of fingerprints. Fingerprints are a well-established forensic identification tool and numerous fingerprint databases and collections exist worldwide for purposes of identification and confirmation/verification of identity. The advantage of utilizing nucleic acid obtained from a fingerprint provides further confirmatory and conclusive evidence of identification and further, association of an identified individual with the surface and so the place or object from which the fingerprint nucleic acid was obtained.
- the nucleic acid recovered from denim using the methods described herein can be used for identification of the organism from which the biological material or biological sample containing the nucleic acid was obtained as discussed supra.
- kits for extraction of nucleic acid from a matrix including, but not limited to, a biological material that is calcified or otherwise hardened to a solid state, an adhesive or sticky materials thought to contain nucleic acid and denim thought to contain nucleic acid.
- a basic kit can comprise a container having a lysis solution capable of releasing nucleic acid from a matrix, an adhesive and/or sticky material or denim material.
- a kit can also optionally comprise instructions for use.
- the kit can also comprise other optional kit components, such as, for example, a solution comprising a polymer and detergent, magnetically attractable particles, one or more wash solutions, a nucleic acid elution solution, a nucleic acid extraction control, a magnetic device, and a protocol and manual to educate the user and limit error in use.
- kit components such as, for example, a solution comprising a polymer and detergent, magnetically attractable particles, one or more wash solutions, a nucleic acid elution solution, a nucleic acid extraction control, a magnetic device, and a protocol and manual to educate the user and limit error in use.
- the amounts of the various reagents, tubes and magnetic device(s) in the kits also can be varied depending upon a number of factors, such as the optimum purification and/or sensitivity of the process. It is within the scope of these teachings to provide test kits for use in manual applications or test kits for use with automated sample preparation, reaction set-up, detectors or analyzers.
- nucleic acid extraction means are within the scope of the disclosed compositions, methods and kits, provided that the material being analyzed contains nucleic acid or has nucleic acid adhered to the material.
- Bone and tooth samples were cleaned using mild detergent solution, overnight air drying, and removing the exterior layer using a sanding stone attached to a Dremel tool ( Dremel, Madison, Wl). Larger pieces of bones were chopped into small pieces. Pieces of bone and tooth were pulverized using a fresh or cleaned grinder (e.g., a Cryo-mill, BioSpect Products, Bartlesville, OK). Pulverized bone or tooth power was stored at room temperature.
- a fresh or cleaned grinder e.g., a Cryo-mill, BioSpect Products, Bartlesville, OK. Pulverized bone or tooth power was stored at room temperature.
- Chewed chewing gum samples were stored at room temperature.
- the gum was flattened ( ⁇ 3 mm thick) in a clean Petri dish.
- the lid was closed and the Petri dish was stored at -80 Q C for several hours for hardening.
- the hardened gum was cut into 8 equal sized portions. One portion of the gum was used for extraction of DNA.
- Tape lift samples from various sources were prepared. From each sample, a 1 .5 cm X 2.5 cm piece of tape (containing the biological sample) was used for processing. The blood or saliva was dry before removing by a tape lift procedure and then adding the lysis reagent solution. For the tape + biological fluid samples, 0.5-5 ⁇ _ of blood or saliva was added directly to the adhesive side of the tape. For the tape lift samples, 2 ⁇ _ of human blood or 5 ⁇ _ of saliva was added to a glass slide. Once the biological material was dry, the biological material was tape lifted. Tape lift samples containing skin cells were also collected from either the inside of a shirt collar or the inside of a shirt cuff from worn shirt samples.
- Denim fabric samples (non-black denim) were prepared. 1 uL of blood in replicates of 4 were obtained using a 5 mm punch where blood had been applied and allowed to air dry.
- the lysis reaction with the Tris-Cl-buffered lysis reagent solution was carried out in a LySepTM column (Applied Biosystems) in a 500 uL volume in the presence of 3 uL reducing agent (1 M) and 3 uL 20 mg/mL enzyme. The column was incubated for 40 min at 56°C on a thermal mixer. DNA extraction was done using the AutoMate ExpressTM (Applied Biosystems) following the manufacturers recommended protocol. DNA quantification was done using Quantifiler DuoTM kit (Applied Biosystems).
- Denim fabric samples prepared with 20 uL of buccal epithelial cells in 6 replicates were analyzed as described for blood on denim.
- Blood on black denim was 2 uL of blood in 3 replicates and was analyzed as described for denim above.
- Lysis solution was prepared to process a number of samples in duplicate or triplicate.
- the solution was freshly prepared by mixing 220 ⁇ of 250-500 mM of chelating agent, pH 7.9 to 8.5 containing 1 % w/v of at least one detergent to which was added 0.5-1 mg/mL enzyme and freshly prepared reducing agent in DNase free water at a final concentration of 10-100 mM.
- the lysis mixtures were incubated with or without shaking at a temperature in the range of approximately 50-70 Q C for a period of 90 minutes to 2 hours.
- Table 6 illustrates lysis solutions that can be used to extract nucleic acid from solid biological materials and adhesive materials containing or thought to contain biological samples containing nucleic acid.
- Tris-CI-buffered lysis reagent solution was prepared to process a number of samples in duplicate, triplicate or 6-replicates.
- the solution was freshly prepared by mixing 220 ⁇ _ of 250-1000 mM of chelating agent, pH 7.9 to 8.5 containing 0.5 - 3% w/v of at least one detergent to which was added 0.5-50 mg/mL enzyme and freshly prepared reducing agent in DNase free water at a final concentration of 10-100 mM.
- the lysis mixtures were incubated with or without shaking at a temperature in the range of approximately 50-70 Q C for a period of 90 minutes to 2 hours.
- Proteinase K 0.5to1 mg/mL 0.5to1 mg/mL 0.5to 1 mg/mL 0.5to1 mg/mL 0.5to 1 mg/mL 0.5to1 mg/mL 0.5to1 mg/ml_
- 230 ⁇ _ of freshly prepared Lysis solution was added to 50 - 200 mg of bone or 10 mg of tooth powder, in a 2.0 ml. screw cap tube. The lid was closed and the tube was incubated at 56 Q C in an Eppendorf® Thermomixer R (Eppendorf North America, Westbury, NYJ, at 1 100 rpm for 2 hours. At the end of incubation, the tube was centrifuged at 10,000 x g for 5 min and clear supernatant/lysate (maximal of 210 ⁇ _) was transferred to a fresh 1 .5 ml. microfuge tube containing 300 ⁇ _ of PrepFilerTM Lysis Buffer and processed for isolation of DNA according to the manufactures large volume protocol. Basically, 15 uL of PrepFilerTM Magnetic particles and 300 uL 99.5%
- Isopropanol is added followed by gentle mixing.
- the particles are was twice with PrepFilerTM Wash Buffer A using 600 uL and then 300 uL of Buffer A followed by one wash with 300 uL PrepFilerTM Wash Buffer B.
- the nucleic acid is then eluted into 50 uL of PrepFilerTM Elution Buffer as outlined in the PrepFiler Manual and PrepFiler
- DNA from the lysate was isolated by following the large-sample protocol (for use with 500 ⁇ _ of PrepFilerTM lysis buffer) as described by the manufacturer (Applied Biosystems, PrepFilerTM Forensic DNA Extraction Kit User Guide. PN 4390932 Rev. B, (2008)).
- the quantity of DNA was determined by Quantifiler ® or Quantifiler DUO® Human DNA Quantification Kit (Applied Biosystems, Foster City, CA) using 2 ⁇ _ of the DNA extract as described in the User's Manual (Applied Biosystems, Quantifiler ® Human DNA Quantification Kit and Quantifiler ® Y Human Male DNA Quantification Kit. User's Manual. PPN 4344790 Rev. B, (2003)). PCR was performed on the 7500 Real-Time PCR System and the data were analyzed using 7500 System SDS Software v1 .2.3 (Applied Biosystems, Foster City, CA).
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16185671.1A EP3124596A1 (de) | 2009-09-16 | 2010-09-14 | Lysepuffer zur extraktion von nukleinsäuren |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24313609P | 2009-09-16 | 2009-09-16 | |
US36038610P | 2010-06-30 | 2010-06-30 | |
US37934610P | 2010-09-01 | 2010-09-01 | |
PCT/US2010/048833 WO2011034864A1 (en) | 2009-09-16 | 2010-09-14 | Lysis buffers for extracting nucleic acids |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16185671.1A Division EP3124596A1 (de) | 2009-09-16 | 2010-09-14 | Lysepuffer zur extraktion von nukleinsäuren |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2478088A1 true EP2478088A1 (de) | 2012-07-25 |
EP2478088B1 EP2478088B1 (de) | 2016-08-31 |
Family
ID=42967513
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10755294.5A Active EP2478088B1 (de) | 2009-09-16 | 2010-09-14 | Lysepuffer zur extraction von nukleinsäuren |
EP16185671.1A Withdrawn EP3124596A1 (de) | 2009-09-16 | 2010-09-14 | Lysepuffer zur extraktion von nukleinsäuren |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16185671.1A Withdrawn EP3124596A1 (de) | 2009-09-16 | 2010-09-14 | Lysepuffer zur extraktion von nukleinsäuren |
Country Status (3)
Country | Link |
---|---|
US (5) | US9447409B2 (de) |
EP (2) | EP2478088B1 (de) |
WO (1) | WO2011034864A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2478088B1 (de) | 2009-09-16 | 2016-08-31 | Life Technologies Corporation | Lysepuffer zur extraction von nukleinsäuren |
WO2014018195A1 (en) | 2012-06-21 | 2014-01-30 | Monsanto Technology Llc | Lysis buffer and methods for extraction of dna from plant material |
US9957500B2 (en) | 2015-02-26 | 2018-05-01 | Stem Arts Projects, Llc | Continuous flow nucleic acid extraction apparatus and method of use thereof |
JP6886965B2 (ja) | 2015-08-11 | 2021-06-16 | ステム アーツ プロジェクツ, エルエルシー | 携帯型核酸抽出器具及びその使用方法 |
US11168318B2 (en) * | 2017-02-15 | 2021-11-09 | Ande Corporation | Systems and methods for rapid nucleic acid extraction, purification and analysis from bone and tooth |
WO2019136021A1 (en) * | 2018-01-03 | 2019-07-11 | Sakkos Jonathan Konstantine | Biological assembly including biological component and shield |
US20200071774A1 (en) * | 2018-08-31 | 2020-03-05 | Invisidex, Inc. | Systems and Methods for Securing Anti-Tamper Label and Tape Adhesive Chemistry with Molecular Taggants |
CN109182332A (zh) * | 2018-09-30 | 2019-01-11 | 浙江天杭生物科技股份有限公司 | 一种从临床样品中快速简便提取核酸的方法 |
JP2023526038A (ja) * | 2020-05-14 | 2023-06-20 | バイオエコー ライフ サイエンシズ ゲーエムベーハー | 上昇させた温度での核酸の単離 |
CN114295826A (zh) * | 2021-12-22 | 2022-04-08 | 上海思路迪医学检验所有限公司 | 一种外泌体裂解试剂及外泌体pd-l1蛋白检测试剂盒 |
CN115628951A (zh) * | 2022-10-18 | 2023-01-20 | 南京火眼金睛安全科技有限公司 | 一种用于痕量毒品检测的人体毛发裂解液及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070898A2 (en) * | 2002-02-19 | 2003-08-28 | Choicepoint Asset Company | Selective extraction of dna from groups of cells |
US20060188892A1 (en) * | 2005-02-18 | 2006-08-24 | Ambion, Inc. | Enzymatic digestion of tissue |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ275286A (en) * | 1993-10-22 | 1998-08-26 | Amgen Inc | Detecting target nucleic acid sequences using labelled rna probe hybridization and rnase digestion |
AU682538B2 (en) * | 1993-11-16 | 1997-10-09 | Becton Dickinson & Company | Process for lysing mycobacteria |
ATE184013T1 (de) * | 1994-06-14 | 1999-09-15 | Invitek Gmbh | Universelles verfahren zur isolierung und reinigung von nukleinsäuren aus extrem geringen mengen sowie sehr stark verunreinigten unterschiedlichsten ausgangsmaterialien |
DE69943048D1 (de) * | 1998-08-18 | 2011-01-27 | Dermtech International San Diego | Methode zum nachweis biologischer faktoren in der epidermis |
US7820375B2 (en) * | 2001-09-07 | 2010-10-26 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Use of a protein of the CRMP family for treating diseases related to the immune system |
US20060078923A1 (en) * | 2003-04-02 | 2006-04-13 | Mckernan Kevin | Method for isolating nucleic acids |
US8426126B2 (en) | 2004-03-18 | 2013-04-23 | Applied Biosystems, Llc | Modified surfaces as solid supports for nucleic acid purification |
US20070015165A1 (en) * | 2005-07-13 | 2007-01-18 | Sigma-Aldrich Co. | Method for the isolation of RNA from biological sources |
US8080645B2 (en) * | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
WO2008134470A2 (en) * | 2007-04-25 | 2008-11-06 | 3M Innovative Properties Company | Methods for nucleic acid amplification |
AU2008343745B2 (en) * | 2007-10-01 | 2012-05-10 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection and transport system and methods of use |
EP2250285A2 (de) | 2008-02-15 | 2010-11-17 | Life Technologies Corporation | Verfahren und kits zur extraktion von dna |
US8357672B2 (en) * | 2008-06-13 | 2013-01-22 | Bio-Rad Laboratories, Inc. | Cell lysis reagent for isolation of RNA |
EP2478088B1 (de) | 2009-09-16 | 2016-08-31 | Life Technologies Corporation | Lysepuffer zur extraction von nukleinsäuren |
WO2012018638A2 (en) * | 2010-07-26 | 2012-02-09 | Biomatrica, Inc. | Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures |
US11168318B2 (en) | 2017-02-15 | 2021-11-09 | Ande Corporation | Systems and methods for rapid nucleic acid extraction, purification and analysis from bone and tooth |
-
2010
- 2010-09-14 EP EP10755294.5A patent/EP2478088B1/de active Active
- 2010-09-14 WO PCT/US2010/048833 patent/WO2011034864A1/en active Application Filing
- 2010-09-14 US US12/882,194 patent/US9447409B2/en active Active
- 2010-09-14 EP EP16185671.1A patent/EP3124596A1/de not_active Withdrawn
-
2016
- 2016-08-12 US US15/235,327 patent/US20160348092A1/en not_active Abandoned
-
2018
- 2018-06-21 US US16/013,938 patent/US10894957B2/en active Active
-
2021
- 2021-01-11 US US17/146,163 patent/US11820978B2/en active Active
-
2023
- 2023-10-12 US US18/379,480 patent/US20240200053A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070898A2 (en) * | 2002-02-19 | 2003-08-28 | Choicepoint Asset Company | Selective extraction of dna from groups of cells |
US20060188892A1 (en) * | 2005-02-18 | 2006-08-24 | Ambion, Inc. | Enzymatic digestion of tissue |
Non-Patent Citations (1)
Title |
---|
See also references of WO2011034864A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2478088B1 (de) | 2016-08-31 |
US20110159485A1 (en) | 2011-06-30 |
US9447409B2 (en) | 2016-09-20 |
US20160348092A1 (en) | 2016-12-01 |
US20180371449A1 (en) | 2018-12-27 |
US10894957B2 (en) | 2021-01-19 |
US20240200053A1 (en) | 2024-06-20 |
US11820978B2 (en) | 2023-11-21 |
US20210198655A1 (en) | 2021-07-01 |
WO2011034864A1 (en) | 2011-03-24 |
EP3124596A1 (de) | 2017-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11820978B2 (en) | Lysis buffers for extracting nucleic acids | |
JP5112064B2 (ja) | 環境サンプルおよび生物学的サンプル中の核酸から夾雑物を除去するためのキットおよび方法 | |
CN102257158B (zh) | 用于dna提取的方法和试剂盒 | |
US20040126796A1 (en) | Extraction of DNA from biological samples | |
CN111254141A (zh) | 核酸提取组合物及其应用,含有该核酸提取组合物的试剂、试剂盒 | |
Bhati et al. | An effective method for saliva stabilization and magnetic nanoparticles based DNA extraction for genomic applications | |
JP2013042750A (ja) | 核酸抽出方法、核酸抽出試薬キットおよび核酸抽出用試薬 | |
EP2951314B1 (de) | Festes medium zur lagerung von biologischem material | |
JP2023521803A (ja) | ウイルス核酸の検出用製品及びその検出方法 | |
Chiou et al. | Extraction of human DNA for PCR from chewed residues of betel quid using a novel “PVP/CTAB” method | |
TW201213805A (en) | Lysis buffers for extracting nucleic acids | |
Arbi et al. | A simple, rapid and efficient method for the extraction of genomic DNA from Allium roseum L.(Alliaceae) | |
AU2020244838B2 (en) | Methods of detecting microbial content in cannabis | |
CN109457023B (zh) | 鉴定皂荚性别的基因组合、ssr引物组合、鉴定方法和应用 | |
Nihad et al. | Comparative assessment of quick and cost-efficient quality DNA extraction methods from rice leaves. | |
RU2400537C2 (ru) | Способ выделения и очистки дезоксирибонуклеиновых кислот | |
CN114317524B (zh) | 用于粮食籽粒附着真菌dna提取的试剂、试剂盒及提取方法 | |
TW202325372A (zh) | 戶外用的簡易式核酸萃取套組以及於戶外萃取樣本的核酸的方法 | |
JP5277497B2 (ja) | 土壌から抽出したrnaの精製法 | |
EP4414458A1 (de) | Collect & extract - lösung für die sammlung und lagerung biologischer probentypen zur extraktion von biomolekülen | |
US20090269743A1 (en) | DNA Collection Sticker and Method for Isolating DNA From the Sticker | |
JP2004008107A (ja) | 核酸抽出同時精製法 | |
CN111197092A (zh) | 利用线粒体分子标记鉴定樱桃实叶蜂的方法及其应用 | |
CN110079519A (zh) | 一种经济高效的淡水鱼类dna提取方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120314 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: LIU, YINGJIE (JASON) Inventor name: STRAY, JAMES |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20140725 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20160513 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602010036035 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 825002 Country of ref document: AT Kind code of ref document: T Effective date: 20161015 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: LIFE TECHNOLOGIES CORPORATION |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20160831 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 825002 Country of ref document: AT Kind code of ref document: T Effective date: 20160831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160930 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161130 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170102 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602010036035 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160914 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160930 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160930 |
|
26N | No opposition filed |
Effective date: 20170601 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 8 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160914 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20100914 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160930 Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 9 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160831 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20230925 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230926 Year of fee payment: 14 Ref country code: DE Payment date: 20230918 Year of fee payment: 14 |